Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults

Clinical trial NCT01263691 · COMPLETED

Trial details

NCT number: NCT01263691
Sponsor: Emergent BioSolutions
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bacillus Anthracis (Anthrax) Infection

Start date: 2010-12-01
Primary completion: 2012-05-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.